Deep residual inception encoder‐decoder network for amyloid PET harmonization

Multiple positron emission tomography (PET) tracers are available for amyloid imaging, posing a significant challenge to consensus interpretation and quantitative analysis. We accordingly developed and validated a deep learning model as a harmonization strategy.

• Publication year

  2022

• Venue

  Alzheimer's & Dementia

• Publication date

  2022-02-09

• Fields of study

  Medicine, Computer Science

• Identifiers
  DOI 10.1002/alz.12564PMID 35142053PMCID 9360199
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Deep residual inception encoder‐decoder network for amyloid PET harmonization

  2022cited by this paper
• Generative Adversarial Networks

  2021cited by this paper
• Baseline demographic, clinical, and cognitive characteristics of the Alzheimer's Prevention Initiative (API) Autosomal‐Dominant Alzheimer's Disease Colombia Trial

  2020cited by this paper
• Deep Residual Inception Encoder–Decoder Network for Medical Imaging Synthesis

  2020cited by this paper
• Predicting Alzheimer’s disease progression using multi-modal deep learning approach

  2019cited by this paper
• OASIS-3: Longitudinal Neuroimaging, Clinical, and Cognitive Dataset for Normal Aging and Alzheimer Disease

  2019cited by this paper
• Comparison of amyloid PET measured in Centiloid units with neuropathological findings in Alzheimer’s disease

  2019cited by this paper
• Novel Deep Learning Models for Medical Imaging Analysis

  2019cited by this paper
• Alzheimer Disease: An Update on Pathobiology and Treatment Strategies

  2019cited by this paper
• The Alzheimer's Prevention Initiative Generation Program: Study design of two randomized controlled trials for individuals at risk for clinical onset of Alzheimer's disease

  2019cited by this paper
• Comparison of 18F‐florbetaben quantification results using the standard Centiloid, MR‐based, and MR‐less CapAIBL® approaches: Validation against histopathology

  2019cited by this paper
• Comparison of Pittsburgh compound B and florbetapir in cross-sectional and longitudinal studies

  2019cited by this paper
• MedGAN: Medical Image Translation using GANs

  2018cited by this paper
• Utilizing the Centiloid scale in cross-sectional and longitudinal PiB PET studies

  2018cited by this paper
• NIA-AA Research Framework: Toward a biological definition of Alzheimer’s disease

  2018cited by this paper
• Standardization of amyloid quantitation with florbetapir standardized uptake value ratios to the Centiloid scale

  2018cited by this paper
• Deep Learning MR Imaging-based Attenuation Correction for PET/MR Imaging.

  2017cited by this paper
• Deep learning Mr imaging–based attenuation correction for PeT/Mr imaging 1

  2017cited by this paper
• Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis.

  2015cited by this paper
• Deep Learning

  2015cited by this paper
• U-Net: Convolutional Networks for Biomedical Image Segmentation

  2015cited by this paper
• The Alzheimer's Disease Neuroimaging Initiative 2 PET Core: 2015

  2015cited by this paper
• The Centiloid Project: Standardizing quantitative amyloid plaque estimation by PET

  2015cited by this paper
• Deep Residual Learning for Image Recognition

  2015cited by this paper
• Partial volume correction in quantitative amyloid imaging

  2015cited by this paper
• The A4 Study: Stopping AD Before Symptoms Begin?

  2014cited by this paper
• Adam: A Method for Stochastic Optimization

  2014cited by this paper
• Deep Learning Based Imaging Data Completion for Improved Brain Disease Diagnosis

  2014cited by this paper
• Early Clinical PET Imaging Results with the Novel PHF-Tau Radioligand [F-18]-T807

  2013cited by this paper
• Amyloid-β Imaging with Pittsburgh Compound B and Florbetapir: Comparing Radiotracers and Quantification Methods

  2013cited by this paper
• Preclinical trials in autosomal dominant AD: implementation of the DIAN-TU trial.

  2013cited by this paper
• Quantitative Analysis of PiB-PET with FreeSurfer ROIs

  2013cited by this paper
• Florbetapir PET analysis of amyloid-β deposition in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: a cross-sectional study.

  2012cited by this paper
• Clinical and biomarker changes in dominantly inherited Alzheimer's disease.

  2012cited by this paper
• Clinical Validation of 18F-AZD4694, an Amyloid-β–Specific PET Radioligand

  2012cited by this paper
• Developing an international network for Alzheimer research: The Dominantly Inherited Alzheimer Network.

  2012cited by this paper
• Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease

  2011cited by this paper
• Using positron emission tomography and florbetapir F18 to image cortical amyloid in patients with mild cognitive impairment or dementia due to Alzheimer disease.

  2011cited by this paper
• Cerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study.

  2011cited by this paper
• In Vivo Imaging of Amyloid Deposition in Alzheimer Disease Using the Radioligand 18F-AV-45 (Flobetapir F 18)

  2010cited by this paper
• Reducing between scanner differences in multi-center PET studies

  2009cited by this paper
• Phase 1 Study of the Pittsburgh Compound B Derivative 18F-Flutemetamol in Healthy Volunteers and Patients with Probable Alzheimer Disease

  2009cited by this paper
• Automated (11)C-PiB standardized uptake value ratio.

  2008cited by this paper
• Potential antecedent marker of Alzheimer disease

  2006cited by this paper
• [11C]PIB in a nondemented population

  2006cited by this paper
• Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B

  2004cited by this paper
• Neuropathological stageing of Alzheimer-related changes

  2004cited by this paper
• Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents.

  2003cited by this paper
• The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease.

  1991cited by this paper

• Accounting for white matter uptake improves between tracer agreement in amyloid PET

  2025cites this paper
• Enhancing Amyloid PET Quantification: MRI-Guided Super-Resolution Using Latent Diffusion Models

  2024cites this paper
• Deep learning-based amyloid PET harmonization to predict cognitive decline in non-demented elderly

  2024cites this paper
• Harmonizing florbetapir and PiB PET measurements of cortical Aβ plaque burden using multiple regions‐of‐interest and machine learning techniques: An alternative to the Centiloid approach

  2024cites this paper
• ArcheD, a residual neural network for prediction of cerebrospinal fluid amyloid‐beta from amyloid PET images

  2024cites this paper
• Image Translation for Estimating Two‐Dimensional Axial Amyloid‐Beta PET From Structural MRI

  2023cites this paper
• Probabilistic estimation for across‐batch compatibility enhancement for amyloid PET

  2023cites this paper
• Neuropsychiatric Symptoms and Commonly Used Biomarkers of Alzheimer’s Disease: A Literature Review from a Machine Learning Perspective

  2023cites this paper
• Lightweight convolutional neural network models for semantic segmentation of in-field cotton bolls

  2023cites this paper
• Longitudinal head-to-head comparison of ^11C-PiB and ^18F-florbetapir PET in a Phase 2/3 clinical trial of anti-amyloid-β monoclonal antibodies in dominantly inherited Alzheimer’s disease

  2023cites this paper
• ArcheD, a residual neural network for prediction of cerebrospinal fluid amyloid-beta from amyloid PET images

  2023cites this paper
• Deep residual inception encoder‐decoder network for amyloid PET harmonization

  2022cites this paper
• International Nuclear Medicine Consensus on the Clinical Use of Amyloid Positron Emission Tomography in Alzheimer’s Disease

  2022cites this paper
• β-amyloid PET harmonisation across longitudinal studies: Application to AIBL, ADNI and OASIS3

  2022cites this paper